California Supreme Court· 8/3/2020

Ixchel Pharma, LLC v. Biogen, Inc.

Citations

9 Cal. 5th 1130
470 P.3d 571
266 Cal. Rptr. 3d 665

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

holding 20 that for at-will contacts, a plaintiff must also allege the defendant engaged in an independently 21 wrongful act
elements of tortious interference with contractual relations and tortious interference with prospective economic advantage claims
“[T]o state a claim for interference with an at-will contract by a third party, the 18 plaintiff must allege that the defendant engaged in an independently wrongful act.”
“[W]e [have] rejected the argument that section 16600 only voids restraints that entirely prohibit an employee from engaging in a profession and not less restrictive limitations that are reasonable.”
“[T]o 27 state a claim for interference with an at-will contract by a third party, the plaintiff must 1 Toyota Motor Sales, U.S.A., Inc., 902 P.2d 740, 748, 751 (Cal. 1995
“We 22 therefore hold that to state a claim for interference with an at-will contract by a third party, the 23 plaintiff must allege that the defendant engaged in an independently wrongful act.”

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Cited by

25 cases in this archive cite this case; the 20 most cited are listed.

Cites

59 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases named Ixchel Pharma, LLC v. Biogen, Inc.

1 other CourtListener record shares this case name.

Ixchel Pharma, LLC v. Biogen, Inc.
Ninth Circuit· 2019-07-16· cited 8×

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.